Animal studies suggest that GLP-1 receptor activation may modulate dopamine signaling in these pathways, potentially dampening the reward value assigned to food stimuli
If youre managing diabetes, follow your healthcare providers recommendations for monitoring blood glucose levels and check your HbA1c every 36 months
The worlds first solid tumor CAR-T therapy, Claudin18.2-targeted satricabtagene autoleucel (satri-cel) from Chinas CARsgen Therapeutics, is not coming to the U.S
Led by our expert nurse practitioners, this approach prioritises your comfort, health, and long-term success
In other words, the drug itself may not directly damage the retina
FDA Approval Details The FDA granted approval based on results from the OASIS clinical trial programme and the SELECT cardiovascular outcomes trial